Sat, Feb 28, 2015, 2:48 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Hyperion Therapeutics, Inc. (HPTX) Message Board

  • rrtzrealmd rrtzrealmd May 2, 2013 9:48 AM Flag

    HAW!!!...what did I tell'ya?!!...

    ...I said yesterday you could expect a stream of meaningless press releases to start anytime now since HPTX would want to stem the bloodletting!...and voila!...this morning they kindly oblige with ONE press release announcing they're acquiring rights to buphenyl and ammonul and ANOTHER press release saying that they acquired "orphan drug exclusivity" for ravicti!...

    ...well, considering they anticipate having only five HUNDRED patients REGARDLESS of whether they're selling ravicti or buphenyl, you have to wonder exacly how much value there is in having "orphan drug exclusivity" -- right?... then again, if ravicti is all so special why does HPTX want to acquire rights to its competitors buphenyl and ammonul?...why pay MILLIONS of dollars to acquire rights to drugs when YOUR drug is allegedly so superior?....

    ...and did you notice this is starting with the earnings report due within the next two weeks?...

    ....and the wheels on the biotech bus go round and round!...round and round!...HAW, HAW, HAW!!!...

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
29.55+1.82(+6.56%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.